Table 1.
Demographic and clinical data for CRS and control subjects. Abbreviations: AERD (Aspirin Exacerbated Respiratory Disease), AFS (Allergic Fungal Sinusitis), AR (Allergic Rhinitis), ASA Sens. (Aspirin Sensitivity), DM (Diabetes Mellitus), GERD (Gastroesophageal Reflux Disease), OSA (Obstructive Sleep Apnea), FESS (Functional Endoscopic Sinus Surgery).
| CRS | Control | P | |
|---|---|---|---|
| Total Enrollment | 328 | 287 | |
|
| |||
| Female – N (%) | 129 (39%) | 166 (58%) | <0.001 |
| Race – N (%) | 0.787 | ||
| White | 289 (88.1%) | 249 (87.1%) | |
| Non-White | 39 (11.9%) | 38 (12.9%) | |
| Ethnicity – N (%) | 0.003 | ||
| Hispanic | 3 (1%) | 15 (5.2%) | - |
| Non-Hispanic | 325 (99.1%) | 272 (94.8%) | - |
| Smoker – N (%) | <0.001 | ||
| Never | 197 (60.1%) | 236 (82.2%) | |
| Ever | 131 (39.9%) | 51 (17.8%) | |
| Comorbidities – N (%) | |||
| Asthma | 162 (49.4%) | 41 (14.4%) | <0.001 |
| AERD | 42 (12.8%) | - | - |
| AFS | 14 (4.3%) | - | - |
| AR | 248 (75.6%) | - | - |
| ASA Sens. | 46 (14.0%) | - | - |
| DM | 24 (7.3%) | - | - |
| GERD | 111 (33.8%) | - | - |
| Hypertension | 92 (28.0%) | - | - |
| OSA | 45 (13.7%) | - | - |
| Nasal Polyps – N (%) | 186 (56.7%) | - | - |
| Prior FESS – N (%) | |||
| Primary | 131 (39.9%) | - | - |
| Revision | 197 (60.1%) | - | - |
| Mean (SD) | Mean (SD) | ||
| Age at Enrollment | 48.6 (15.3) | 40.4 (15.4) | <0.001 |
| SNOT-22 | 46.6 (22.2) | 10.6 (12.2) | <0.001 |
| BMI | 28.0 (5.3) | - | |
| Lund-Mackay CT | 12.3 (6.0) | - | |